A new collaborative study has identified and studied Ebola antibodies that could be used to design universal therapeutics that are effective against many different Ebola species. The findings were recently published in Nature Microbiology.
The Ebola virus causes a severe illness with high mortality rates in humans. Several strategies have been developed to treat Ebola infection, including ZMapp, which has been shown to be effective in non-human primates and has been used under compassionate-treatment protocols in humans.
"The trouble with ZMapp is that although it is effective against the Ebola species that was largely responsible for the last Ebola outbreak, it does not neutralize other Ebola species, including Ebola Bundibugyo, Reston or Sudan," said virologist Alex Bukreyev, co-senior author and a University of Texas Medical Branch at Galveston professor in the department of pathology.
"We identified and studied three naturally-occurring antibodies from human survivors of Ebola Bundibugyo that neutralize and protect against infection with the several different Ebola virus species."
The newly identified antibodies bond at a different site on the Ebola virus than other antibodies currently used to develop Ebola therapies.
Information on the Ebola virus:
According to the Centers for Disease Control, Ebola was first discovered in 1976 near the Ebola River in what is now the Democratic Republic of Congo. Since then, the virus has been infecting people from time to time, leading to outbreaks in several African countries.
Some of the different kinds of Ebola viruses are:
Other authors include UTMB's Natalia Kuzmina, Philipp linykh, Xiaoli Shen, Kai Huang, Palaniappan Ramanathan, Thomas Ksiazek and Alexander Bukreyev; Andrew Flyak, Pavlo Gilchuk, Christopher Gulka, Rebecca Lampley, Nurgun Kose, Hannah King, Gopal Sapparapu, David Wright and James Crowe, Jr. from Vanderbilt University; Charles Murin, Hannah Turner, Marnie Fusco, Erica Ollmann Saphire and Andrew Ward from The Scripps Research Institute as well as Christopher Bryan, Edgar Davidson and Benjamin Doranz from Integral Molecular, Inc.
The study was supported by the Defense Threat Reduction Agency and the National Institutes of Health.
Donna Ramirez | EurekAlert!
Discovery shows promise for treating Huntington's Disease
05.08.2020 | Ecole Polytechnique Fédérale de Lausanne
Carbon monoxide improves endurance performance
05.08.2020 | Universität Bayreuth
An international research team has found a new approach that may be able to reduce bone loss in osteoporosis and maintain bone health.
Osteoporosis is the most common age-related bone disease which affects hundreds of millions of individuals worldwide. It is estimated that one in three women...
Traditional single-cell sequencing methods help to reveal insights about cellular differences and functions - but they do this with static snapshots only...
“Core-shell” clusters pave the way for new efficient nanomaterials that make catalysts, magnetic and laser sensors or measuring devices for detecting electromagnetic radiation more efficient.
Whether in innovative high-tech materials, more powerful computer chips, pharmaceuticals or in the field of renewable energies, nanoparticles – smallest...
An international research team with Prof. Cornelia Denz from the Institute of Applied Physics at the University of Münster develop for the first time light fields using caustics that do not change during propagation. With the new method, the physicists cleverly exploit light structures that can be seen in rainbows or when light is transmitted through drinking glasses.
Modern applications as high resolution microsopy or micro- or nanoscale material processing require customized laser beams that do not change during...
Although no life has been detected on the Martian surface, a new study from astrophysicist and research scientist at the Center for Space Science at NYU Abu...
23.07.2020 | Event News
21.07.2020 | Event News
07.07.2020 | Event News
05.08.2020 | Physics and Astronomy
05.08.2020 | Health and Medicine
05.08.2020 | Earth Sciences